Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.89% | $5.61M | €435.69B | 61.23% | 76 Outperform | |
| Roche Holding AG | 1.24% | $3.68M | CHF287.79B | 44.65% | 73 Outperform | |
| HSBC Holdings | 1.16% | $3.42M | £224.58B | 50.66% | 80 Outperform | |
| AstraZeneca | 1.13% | $3.34M | £213.91B | 18.62% | 80 Outperform | |
| Novartis AG | 1.08% | $3.19M | CHF225.91B | 22.08% | 80 Outperform | |
| Nestlé SA | 1.01% | $2.98M | CHF197.51B | 17.29% | 71 Outperform | |
| Royal Bank Of Canada | 0.93% | $2.74M | $237.44B | 41.36% | 75 Outperform | |
| Toyota Motor | 0.89% | $2.65M | ¥48.55T | 27.64% | 80 Outperform | |
| Siemens | 0.88% | $2.62M | €188.82B | 17.68% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 0.86% | $2.54M | ¥32.98T | 47.20% | 76 Outperform |